This conference will benefit venture capitalists and angel investors who are interested in early-stage life sciences companies. Key attendees will be business development and senior executives from biotech, pharmaceutical and biomedical companies.
Be among the first to see a range of new companies spun off from Massachusetts research institutions, and see new technologies that are available for commercialization through licensing agreements and the creation of new companies.
MTTC will be glad to consider you as a presenter. To see detailed eligibility criteria and to apply please download the LS 2010 Presenter Application.
MTTC will be glad to consider you as an exhibitor. To see detailed eligibility criteria and to apply please download the LS 2010 ExhibitorApplication
Reid Leonard is Executive Director, Worldwide Licensing for Merck & Co., Inc. Based in Boston, Massachusetts, Reid provides guidance on Merck's licensing interests to biotechnology companies, academic institutions, and venture firms. He serves as an initial contact for the scientific evaluation of partnership opportunities through which Merck may collaborate to develop novel therapeutics. Reid's area of responsibility includes the Northeastern United States and Latin America. He also supervises search and evaluation efforts in Canada and India.
Dr. Leonard graduated from Brandeis University with a B.A. in biology and psychology. He earned a Ph.D. in biology from Purdue University and completed postdoctoral training in molecular pharmacology at Caltech. He joined Merck Research Laboratories in 1989 to conduct discovery research on ion channels. After ten years at the bench, Reid joined Merck's licensing group where he has contributed to the identification and execution of academic and biotech partnerships to advance Merck's pipeline.
Produced by |
 |
|
Media Sponsors
